ACC launches cardiovascular disease prevention program in Saudi Arabia

The American College of Cardiology (ACC) and the Saudi Heart Association have launched a series of forums for physicians focused on preventing cardiovascular disease in Saudi Arabia.

The ACC announced the initiative on April 21. On that day, the ACC planned on hosting a forum on Riyadh, Saudi Arabia, during which speakers from the U.S. and Saudi Arabia discussed risk assessment techniques and treatment guidelines. The ACC said that future topics in the series would likely include how risk factors and health conditions effect cardiovascular disease prevention.

Pfizer supports the ACC’s cardiovascular disease prevention program. The ACC has similar programs for physicians in Egypt, Russia, the United Arab Emirates, Mexico, Argentina, Indonesia, Vietnam, Malaysia and China.

“As René Dubos famously stated, we need to ‘think globally, act locally,’” Daniel José Piñeiro, MD, chair of the ACC’s Assembly of International Governors, said in a news release. “To be effective in changing the culture around treating and preventing heart disease, you have to reach clinicians where they live and practice and beyond a single intervention. We are committed to working with our colleagues in Saudi Arabia to implement this program in a way that achieves maximum impact and furthers the College’s mission to prevent cardiovascular disease and improve patient care on a global scale.”

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.